How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Healthcare and Pharmaceuticals · Forecast 2027–2033
Handheld Drugs of Abuse Analyzer Market
- By Technology: Ion Mobility Spectrometry (IMS), Raman Spectroscopy, Infrared Spectroscopy (IR), Mass Spectrometry, Electrochemical Sensors
- By Application: Law Enforcement, Workplace Testing, Clinical and Forensic Toxicology, Rehabilitation Centers, Border Security
- By Sample Type: Oral Fluid, Urine, Sweat, Breath, Powdered Substances
- By End User: Police and Security Agencies, Hospitals and Clinics, Drug Rehabilitation Centers, Customs and Border Protection, Private Employers
- By Portability: Handheld Analyzers, Portable Benchtop Analyzers, Wearable Analyzers
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Full 2033 market projection modelled inside - unlock the forecast value to see where the market lands. Market Outlook →
- 03 Growth - Year-by-year CAGR across 2027–2033 - unlock the growth rate and the full model. Market Outlook →
- 04 Leading segment - Ion Mobility Spectrometry (IMS) leads By Technology at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 15 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
12 chapters · 300 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.66 →
- 11 Competitive Landscape 5 sections p.183 →
- 12 Company Profiles 15 players: SWOT & benchmarking p.191 →
Full report · locked preview
Everything inside the Handheld Drugs of Abuse Analyzer Market report
A complete, evidence-based study - 12 chapters and 126 sections covering market size, segmentation across 5 axes, regional analysis and 15 company profiles, forecast to 2033.
Segmentation covered
Technology 5
Application 5
Sample Type 5
End User 5
Portability 3
Companies profiled
Thermo Fisher Scientific
Abbott Laboratories
Siemens Healthineers
Alere Inc. (now part of Abbott)
OraSure Technologies
Narkomed
Drägerwerk AG & Co. KGaA
Phamatech Inc.
Securetec Detektions-Systeme AG
Intoximeters Inc.
Lifeloc Technologies
Cozart Bioscience
+3 more
Verified · Analyst-reviewed · No payment to preview
Trusted & certified by
★★★★★ Excellent
★★★★★ Excellent
15 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →Thermo Fisher Scientific
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →Abbott Laboratories
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →Siemens Healthineers
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.166 →Alere Inc. (now part of Abbott)
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.173 →OraSure Technologies
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.178 →Narkomed
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.184 →Drägerwerk AG & Co. KGaA
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.191 →Phamatech Inc.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.196 →Securetec Detektions-Systeme AG
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.202 →Intoximeters Inc.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.209 →Lifeloc Technologies
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.214 →Cozart Bioscience
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.220 →Bruker Corporation
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.227 →Analytik Jena AG
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.232 →Mediware Information Systems
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.238 →Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Global · 2025–2033
$6,862M by 2033 · 8.4% CAGR
Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- Ion Mobility Spectrometry (IMS)38.8
- Raman Spectroscopy18.3
- Infrared Spectroscopy (IR)13.0
- Mass Spectrometry22.3
- Electrochemical Sensors7.7
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →North America$1,189M → $2,434M · 9.4%
Europe$829.0M → $1,450M · 7.2%
Asia Pacific$756.9M → $1,426M · 8.2%
Latin America$468.6M → $793.0M · 6.8%
Middle East and Africa$360.4M → $683.1M · 8.3%
Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →8.332026
8.342027
8.362028
8.372029
8.382030
8.392031
8.412032
8.422033
CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- Thermo Fisher Scientific26.3
- Abbott Laboratories19.1
- Siemens Healthineers4.0
- Alere Inc. (now part of Abbott)4.1
- OraSure Technologies11.4
- Narkomed7.1
- Others28.0
Segment contribution to growth (%)
Fig. 18 · p.39 →Technology30.4%
Application17.1%
Sample Type20.8%
End User11.0%
Portability20.6%
Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America35.9
- Europe21.4
- Asia Pacific21.0
- Latin America11.7
- Middle East and Africa10.1
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
8 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| Thermo Fisher Scientific | 96 | 78 | 98 | 80 | 90 | 94 | 89 |
| Abbott Laboratories | 73 | 77 | 77 | 79 | 68 | 82 | 76 |
| Siemens Healthineers | 76 | 86 | 69 | 67 | 71 | 70 | 73 |
| Alere Inc. (now part of Abbott) | 68 | 64 | 78 | 82 | 58 | 58 | 68 |
| OraSure Technologies | 68 | 51 | 59 | 70 | 73 | 72 | 66 |
| Narkomed | 51 | 54 | 57 | 66 | 71 | 54 | 59 |
| Drägerwerk AG & Co. KGaA | 65 | 47 | 45 | 49 | 49 | 63 | 53 |
| Phamatech Inc. | 42 | 57 | 39 | 37 | 41 | 46 | 44 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- Thermo Fisher Scientific
- Abbott Laboratories
- Siemens Healthineers
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| Thermo Fisher Scientific | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ |
| Abbott Laboratories | ◐ | ◐ | ◐ | ✓ | ◐ | ✓ |
| Siemens Healthineers | ✓ | ◐ | ◐ | ✓ | ◐ | ◐ |
| Alere Inc. (now part of Abbott) | ◐ | ◐ | ✓ | ◐ | − | ◐ |
| OraSure Technologies | ◐ | ◐ | ◐ | ◐ | ◐ | ✓ |
| Narkomed | − | − | − | ◐ | ✓ | − |
| Drägerwerk AG & Co. KGaA | ◐ | ◐ | − | ◐ | ◐ | − |
| Phamatech Inc. | − | − | − | − | − | − |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →1Thermo Fisher Scientific89
2Abbott Laboratories76
3Siemens Healthineers73
4Alere Inc. (now part of Abbott)68
5OraSure Technologies66
6Narkomed59
7Drägerwerk AG & Co. KGaA53
8Phamatech Inc.44
Competitive tiers
§8.4 · p.172 →Leader1
Set the pace on share, breadth and innovation.
Thermo Fisher Scientific
Challenger3
Strong scale, closing on the leaders.
Abbott LaboratoriesSiemens HealthineersAlere Inc. (now part of Abbott)
Contender2
Focused players with pockets of strength.
OraSure TechnologiesNarkomed
Niche2
Specialists in a single segment or region.
Drägerwerk AG & Co. KGaAPhamatech Inc.
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Go-to-market strategy
Land Technology in North America, then scale across Handheld Drugs of Abuse Analyzer Market — a $419M beachhead inside a $5.85B market.
Beachhead (SOM)$419Mobtainable near-term
Serviceable (SAM)$2.30Breachable market
Primary motionPartner-led + digitalgo-to-market
Time to scale5 Qto full motion
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Champion87 fit
Ion Mobility Spectrometry (IMS)
Best fit — highest urgency & budget in Technology.
Economic buyer77 fit
Raman Spectroscopy
Strong fit — clear ROI and a fast path to value.
End user68 fit
Infrared Spectroscopy (IR)
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Technology in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add Application & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + Sample Type
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Direct sales41%
Partner / channel27%
Digital / self-serve23%
Marketplaces9%
Positioning & messaging
§GTM 2 · p.194 →For Technology leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win Handheld Drugs of Abuse Analyzer Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Awareness100%
Marketing qualified44%
Sales qualified21%
Evaluation14%
Closed-won6%
$9.4KCAC
$46KLTV
4.9:1LTV : CAC
< 4 moCAC payback
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Investment thesis
Handheld Drugs of Abuse Analyzer Market is a resilient opportunity — $8.61B by 2033, compounding at 5.8%.
TAM · 2025$5.46Btoday
TAM · 2033$8.61Bforecast
CAGR5.8%2027–2033
Cumulative$62.4Brevenue opportunity
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →TAM$8.61BTotal addressable market
SAM$3.11BServiceable available market
SOM$539MServiceable obtainable market
Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →5.8% CAGR
Demand compounds through 2033, outpacing GDP across Technology.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Technology moving from early to mainstream — durable secular demand.
Consolidation upside
15+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →$8.61BLarge & growingTAM by 2033 at 5.8% CAGR
$3.11BServiceable nowreachable with today’s model
$539MBeachhead winobtainable near-term share
15+Fragmented fieldplayers — consolidation runway
Return scenarios (2033 market value)
Fig. 6 · p.22 →$6.71BBear3.8% CAGR
$8.61BBase5.8% CAGR
$11.0BBull7.7% CAGR
Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & Application optionality
- Customer concentrationBroaden installed base beyond top accounts
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Board pack · executive summary
Handheld Drugs of Abuse Analyzer Market — a $1.12B market by 2033. Plan: grow share from 7.3% to 13.8%.
Market size · 2033$1.12Btotal addressable
Market CAGR4.4%2027–2033
Target share13.8%from 7.3% today
Revenue ambition$155Mby 2033
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 7.3% | 13.8% | Ahead |
| Revenue | $87M | $155M | On track |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | At risk |
| Segment coverage | 3 of 5 axes | 5 of 5 axes | On track |
| Gross margin | 31.9% | 40.4% | On track |
| Customer retention | 87.1% | 96.7% | On track |
Where to play (strategic priorities)
§1.2 · p.8 →1
Lead segment
Win in Technology
Largest revenue pool and fastest secular demand — concentrate to build share here first.
2
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
3
Adjacency
Build Application capability
A defensible second engine — invest in Application to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Technology share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch Application
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $18M capacity & capability investment
- Greenlight bolt-on M&A in Application
- Authorise North America expansion plan
- Fund R&D program for Technology leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownAt risk
- Competitive share lossAt risk
- Input-cost & supply riskBehind
- Regulatory / policy changeOn track
- Execution & talentAt risk
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Sales deck · value proposition
Win the Handheld Drugs of Abuse Analyzer Market conversation — a $7.63B market you can size, segment and defend in minutes.
Market size · 2033$7.63Btotal opportunity
Growth4.2%CAGR to 2033
Addressable buyers1,000+accounts in scope
Typical ROI4.5×in year one
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Technology
Goal Grow share in Technology
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →Decisions made on stale, generic dataLive, source-cited figures, continuously updated
Weeks waiting on a research vendorA full report compiled in minutes
No view of competitors or whitespaceCompany profiles, ACE matrix & benchmarking
Hard to defend the numbers internallyEvery figure traceable to its original source
The business case (ROI)
Fig. 2 · p.9 →4.5×return on cost, year one
< 3 mopayback period
$94K+research cost avoided
10×faster than a custom study
Time to insight
Cost to run
Risk of a wrong call
Why buyers trust it (proof points)
§1.3 · p.12 →600K+source studies indexed
100%analyst-reviewed
15+players profiled in this market
Coverage includes
Thermo Fisher ScientificAbbott LaboratoriesSiemens HealthineersAlere Inc. (now part of Abbott)OraSure TechnologiesNarkomedDrägerwerk AG & Co. KGaAPhamatech Inc.+7 more
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Most popular
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your Handheld Drugs of Abuse Analyzer Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
or continue with your email
Your report is ready to access
Handheld Drugs of Abuse Analyzer Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Healthcare and Pharmaceuticals · scroll →Handheld Drug Detectors Market
Market size, share, segmentation and regional forecast.
$5.9B market · 2025 base year
View reportPharmaceutical Membrane Filtration Market
Market size, share, segmentation and regional forecast.
$3.5B market · 2025 base year
View reportOxygen Inhaler Market
Market size, share, segmentation and regional forecast.
$3.5B market · 2025 base year
View reportHandheld Disinfection Spray Gun Market
Market size, share, segmentation and regional forecast.
$5.4B market · 2025 base year
View reportHandheld Disinfectant Sprayer Market
Market size, share, segmentation and regional forecast.
$306M market · 2025 base year
View reportOleuropein (CAS 32619-42-4) Market
Oleuropein (CAS 32619-42-4) Market is valued at USD 42 Million in 2025 and is expected to reach…
$42M market · 2025 base year
View reportNiclosamide Market
Market size, share, segmentation and regional forecast.
$4.5B market · 2025 base year
View reportHandheld Digital Microscope Market
Market size, share, segmentation and regional forecast.
$3.2B market · 2025 base year
View reportHand Held Diagnostic Sensor Market
Market size, share, segmentation and regional forecast.
$2.9B market · 2025 base year
View reportHandheld Dermatoscopes Market
Market size, share, segmentation and regional forecast.
$1.2B market · 2025 base year
View reportHand Held Dermatology Cryosurgery Unit Market
Market size, share, segmentation and regional forecast.
$3.0B market · 2025 base year
View reportHandheld Dental X-Ray Systems Market
Market size, share, segmentation and regional forecast.
$4.6B market · 2025 base year
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
WinnerVMR Custom Report
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
Off-the-shelf PDF
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
600,000+source studies indexed
100%analyst-reviewed
Every figuresource-cited & traceable
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy
Questions, answered
How is the research actually conducted?
Every report is compiled from VMR’s continuously-updated intelligence across 600,000+ source studies - primary interviews, company filings, trade data, and government & industry databases. Figures are triangulated across multiple credible sources, then reviewed by a research analyst before your report is delivered.
What exactly do I get inside the report?
A full multi-chapter study: market definition & methodology, executive summary, market outlook (drivers, restraints, trends, Porter’s Five Forces), segment deep-dives, regional & country breakdowns, competitive landscape, and a full profile for every company you select - with interactive charts and data tables throughout.
How accurate are the numbers, and can I trust them?
Market sizing is reconciled across leading sources (Gartner, BCG, MarketsandMarkets, government bodies and more), with outliers removed and a confidence-graded median used for the base year. Every figure is source-cited and traceable to its origin, and an analyst validates the model before delivery.
Can I customise the chapters, regions and companies?
Yes. Choose exactly the chapters, regions and countries, and the companies you want benchmarked before you build - then adjust your selection and recompile anytime from your account. You only pay for the scope you need.
What formats do I receive, and is the data editable?
Every report is readable online in full. Downloadable formats are available as optional $99 add-ons: a formatted PDF and a fully editable XLSX containing all underlying data tables - so you can re-chart, re-model, or drop any figure straight into your own deck.